Aug 5, 2026 09:17AM
Jul 21, 2026 09:18AM
Jul 21, 2026 09:17AM
Jun 1, 2026 07:01AM
Jun 1, 2026 07:00AM
May 26, 2026 08:00AM
May 26, 2026 08:00AM Citius Oncology Announces Presentation of LYMPHIR® Phase 1 Combination Study Data at the 2026 American Society of Clinical Oncology Annual Meeting
May 15, 2026 04:30PM
May 15, 2026 04:30PM
May 6, 2026 05:57AM
May 5, 2026 08:00PM
Apr 29, 2026 08:00AM
Apr 24, 2026 04:30PM
Apr 24, 2026 04:30PM Citius Pharmaceuticals Announces Closing of Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules
Apr 24, 2026 08:00AM
Apr 24, 2026 08:00AM
Mar 31, 2026 09:13AM
Mar 31, 2026 09:11AM
Mar 24, 2026 08:00AM
Mar 10, 2026 08:47AM
Mar 10, 2026 08:47AM Citius Oncology Announces Positive Topline Results from Investigator‑Initiated Phase 1 Study of LYMPHIR™ in Combination with Pembrolizumab in Relapsed or Refractory Gynecologic Cancers
Mar 4, 2026 09:15AM
Mar 4, 2026 09:15AM
Feb 24, 2026 08:00AM
Feb 13, 2026 08:00AM
Feb 13, 2026 08:00AM
Feb 11, 2026 08:02AM
Feb 11, 2026 08:00AM Citius Oncology Expands International Distribution of LYMPHIR™ to European Union Through Exclusive Agreement with Uniphar
Dec 23, 2025 04:31PM
Dec 23, 2025 04:30PM
Dec 23, 2025 04:30PM
Dec 10, 2025 04:30PM
Dec 10, 2025 04:30PM
Dec 9, 2025 08:30AM
Dec 9, 2025 08:30AM Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules
Dec 4, 2025 08:37AM
Dec 4, 2025 08:37AM
Dec 4, 2025 08:30AM
Dec 1, 2025 12:08PM
Dec 1, 2025 12:00PM
Nov 25, 2025 08:00AM
Nov 21, 2025 08:38AM Citius Oncology partners with Verix AI for LYMPHIR launch
Nov 21, 2025 08:37AM
Oct 21, 2025 04:30PM
Oct 21, 2025 04:30PM
Oct 21, 2025 08:01AM
Oct 21, 2025 08:00AM
Oct 20, 2025 08:38AM
Oct 20, 2025 08:37AM Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIR™ Commercial Launch
Oct 17, 2025 05:00PM

328,149 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All